Completed

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

I1F-MC-RHCD - ClinicalTrials.gov - NCT03073200

The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis. Note: the study design may differ if you reside outside of US or Canada, please consult with the appropriate investigator for more details.
How long will I be in the trial?
Your participation could last up to 132 weeks and include 34 visits to the study center.
Email
Completed

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

I1F-MC-RHCD - ClinicalTrials.gov - NCT03073200

The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis. Note: the study design may differ if you reside outside of US or Canada, please consult with the appropriate investigator for more details.
How long will I be in the trial?
Your participation could last up to 132 weeks and include 34 visits to the study center.
Email

Key Requirements

Age :

6-18

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

6-18

Sex

All

Participants must

Participant (child or adolescent) must have a diagnosis of moderate-to-severe plaque-type psoriasis for at least 6 months prior to baseline as determined by the investigator

Male participant must agree to use a reliable method of birth control during the study

Female participant of childbearing potential must test negative for pregnancy and agree to use a reliable method of birth control or agree not to be sexually active during the study and for at least 12 weeks following the last dose of study medication

Participant and their parent or legal guardian must be able to understand and fully participate in the activities of the clinical study

Participants must NOT

Participant must not have any active or recent infection within 4 weeks of the first dose of study medication

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

Ixekizumab, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

195

Trial Dates

March 2017 - March 2021

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

6-18

Sex

All

Participants must

Participant (child or adolescent) must have a diagnosis of moderate-to-severe plaque-type psoriasis for at least 6 months prior to baseline as determined by the investigator

Male participant must agree to use a reliable method of birth control during the study

Female participant of childbearing potential must test negative for pregnancy and agree to use a reliable method of birth control or agree not to be sexually active during the study and for at least 12 weeks following the last dose of study medication

Participant and their parent or legal guardian must be able to understand and fully participate in the activities of the clinical study

Participants must NOT

Participant must not have any active or recent infection within 4 weeks of the first dose of study medication

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

Ixekizumab, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

195

Trial Dates

March 2017 - March 2021

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Psoriasis Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?